lubiprostone has been researched along with Visceral Pain in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Creekmore, AL; Hong, S; Wiley, JW; Xue, J; Zhu, S | 1 |
| Hong, S; Wiley, JW; Zhang, S; Zheng, G; Zhu, S; Zong, Y | 1 |
| Morgan, B | 1 |
3 other study(ies) available for lubiprostone and Visceral Pain
| Article | Year |
|---|---|
Chronic stress-associated visceral hyperalgesia correlates with severity of intestinal barrier dysfunction.
Topics: Animals; Gastrointestinal Diseases; Hyperalgesia; Intestinal Mucosa; Lubiprostone; Male; Permeability; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Stress, Psychological; Visceral Pain | 2018 |
Chronic stress and intestinal permeability: Lubiprostone regulates glucocorticoid receptor-mediated changes in colon epithelial tight junction proteins, barrier function, and visceral pain in the rodent and human.
Topics: Animals; Caco-2 Cells; Cell Line; Chloride Channel Agonists; CLC-2 Chloride Channels; Colon; Humans; Intestinal Mucosa; Lubiprostone; Male; Permeability; Rats; Receptors, Glucocorticoid; Stress, Psychological; Tight Junction Proteins; Visceral Pain | 2019 |
Drug development: A healthy pipeline.
Topics: Animals; Benzimidazoles; Benzofurans; Bile Acids and Salts; Carbolines; Colesevelam Hydrochloride; Colestipol; Disease Models, Animal; Enteric Nervous System; Female; Humans; Imidazoles; Indoles; Irritable Bowel Syndrome; Loperamide; Lubiprostone; Male; Mice; Natriuretic Peptides; Peptides; Phenylalanine; Receptors, Serotonin, 5-HT3; Receptors, Serotonin, 5-HT4; Rifamycins; Rifaximin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Visceral Pain | 2016 |